Heron Therapeutics (HRTX) HTX-011 Differentiated, Which Should Drive Uptake - Jefferies

March 19, 2018 11:33 AM EDT Send to a Friend
Jefferies analyst Biren Amin reiterated a Buy rating and $30 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login